Toshima-ku, Japan

Aya Fujino



 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Aya Fujino: Innovator in Pharmaceutical Research

Introduction

Aya Fujino is a prominent inventor based in Toshima-ku, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents for various mental and physical health conditions. With a total of 3 patents to her name, Fujino is recognized for her innovative approaches to complex health issues.

Latest Patents

Fujino's latest patents focus on phenylpyrazole derivatives, which serve as prophylactic or therapeutic agents for a range of conditions including dementia, Alzheimer's disease, attention-deficit hyperactivity disorder, schizophrenia, eating disorders, obesity, diabetes, hyperlipidemia, sleep disorders, narcolepsy, sleep apnea syndrome, circadian rhythm disorder, depression, and allergic rhinitis. These compounds are represented by a specific formula, which includes pharmaceutically acceptable salts, showcasing her commitment to advancing medical science.

Career Highlights

Aya Fujino is currently employed at Taisho Pharmaceutical Co., Ltd., where she continues to push the boundaries of pharmaceutical research. Her work has not only contributed to the scientific community but has also aimed to improve the quality of life for individuals suffering from various health conditions.

Collaborations

Fujino collaborates with esteemed colleagues such as Toshio Nakamura and Makoto Tatsuzuki, further enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Aya Fujino stands out as a dedicated inventor in the pharmaceutical industry, with her innovative work on phenylpyrazole derivatives paving the way for new treatments. Her contributions reflect a deep commitment to addressing significant health challenges through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…